ViennaLab Diagnostics GmbH

Improve the quality of life for cystic fibrosis (CF) patients by timely detection of CFTR gene variants.

Cystic Fibrosis (CF) is the most prevalent life-limiting autosomal recessive disorder in the Caucasian population. ViennaLab offers population-tailored CF StripAssays® including 46 common Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutations and the polyT variant 5T/7T/9T in intron 8.

 

Cystic Fibrosis (CF)

 

  • CF patients typically show decreased pulmonary function accompanied by persistent respiratory infections, pancreatic insufficiency, malnutrition and male infertility.
  • The disease prevalence is estimated to be 1 in 2,500 to 4,000 live births.
  • Clinical manifestations vary in severity depending on the underlying CFTR mutations, ranging from classical CF to the milder forms of CFTR-related disorders.
  • Therapies to improve the quality of life of CF patients are available and aim for the prevention of complications and controlling the symptoms.
  • In newborn screening, CFTR genotyping enables early diagnosis and minimizes emotional stress for parents.

 

ProductReg. Stat.REFUnit SizeIFUBrochure
CF StripAssay® IVDR CE01234-41010 tests

PDF

PDF

CF StripAssay® TUR IVDR CE01234-42010 tests

PDF

PDF

CF StripAssay® GER IVDR CE01234-43010 tests

PDF

PDF

CF StripAssay® EXT IVDR CE01234-44010 tests

PDF

We use Matomo to analyze the access to our website. We pass on information about your use of our website to our partners for analysis. Our partners may combine this information with other data that you have provided to them or that they have collected as part of your use of the services. I agree.

Deny Allow